Results 131 to 140 of about 838,980 (200)

Prevalence and Predictors of Substance Use Disorder Due to Gabapentinoids in Patients With Chronic Non-Cancer Pain: A Cross-Sectional Study. [PDF]

Health Sci Rep
Kufeld N, Weckbecker K, Münster E, Scherbaum N, Specka M, Just J.   +5 more
europepmc   +1 more source

Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma. [PDF]

Clin Pharmacokinet
Sinnollareddy M, Sanghavi K, Gibiansky L, Li T, Putnins M, Mohamed MF, Patah P, Favaro E, Gupta M, Parikh A, Xu S.   +10 more
europepmc   +1 more source

Mental health disorders and risk of solitary confinement among incarcerated individuals: a nationwide longitudinal cohort study from Norway. [PDF]

BMJ Ment Health
Lokdam NT, Riksheim Stavseth M, Favril L, Scarth M, Tverborgvik T, Andersen LH, Bukten A.   +6 more
europepmc   +1 more source

Long-Acting Injectable Antipsychotics in Schizophrenia and Comorbid Substance Use Disorder: A Systematic Review of the Literature. [PDF]

Brain Sci
Lupi M, Carano A, Rossi E, Carlucci M, Barioglio A, Giri M, De Berardis D, Volpe U, Martinotti G.   +8 more
europepmc   +1 more source